Simile Raises $200M Series B at $2B Valuation

Simile, a simulation technology company, has raised $200 million in Series B funding at a $2 billion valuation. This latest round follows a $100 million Series A secured just five months prior, bringing total disclosed funding to $300 million.

Investors

The round was led by Greenoaks. Additional participants included Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, CVS Health Ventures, and Definition.

Simile Use of Funds

Simile plans to use the new capital to accelerate the development of its foundation model for human behavior and to scale its simulation platform.

About Simile

Founded to revolutionize decision-making, Simile specializes in simulation technology that models human behavior. The company provides a platform that allows organizations to evaluate complex scenarios and decisions in a virtual environment before implementing them in the real world. Its technology is currently used across industries such as healthcare, financial services, and media to test products, model market dynamics, and simulate social research.

Funding Details

Company Website: https://simile.ai

Company: Simile
Raised: $200M
Round: Series B
Funding Date: July 31, 2026
Lead Investor: Greenoaks
Additional Investors: Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, CVS Health Ventures, Definition
Software Category: AI/Simulation